Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MG Pharma Inc. is a Japanese pharmaceutical and functional food company and a subsidiary of Rohto Pharmaceutical Co., Ltd. Founded in 1969 and acquired by Rohto in 2002, the company specializes in the research and development of lipid-related functional ingredients and lifestyle-related disease treatments. Its core technologies include the proprietary globin peptide (METAP), which suppresses fat absorption and promotes fat breakdown, and LICONINE, a licorice extract for metabolic health. MG Pharma's products range from over-the-counter pharmaceuticals to "Foods with Function Claims" (FFC) targeting visceral fat, neutral fat, and liver protection.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MG Pharma.